Hospital
Livingston Hospital and Healthcare Services, INC.
Livingston Hospital and Healthcare Services, INC. was paid $4.94M by Medicaid between Jan 2018 and Dec 2024, across 88 billing codes. Its largest line is 99285, emergency room visit (most serious) — 11% of everything it billed.
33Billing provider infoLIVINGSTON HOSPITAL AND HEALTHCARE SERVICES, INC.
SALEM, KY 42078
SALEM, KY 42078
33aNPI1588640254assigned 12/15/2005
33bProvider typeCritical Access Hospital
28Total paid$4.94M
24GClaims106,026
24DCodes billed88
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Kentucky
Rank by total paid#15 of 16
Median peer was paid$11.73M
This provider vs. median0.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,447 | $551K | |
| 2019 | 14,692 | $539K | |
| 2020 | 13,990 | $520K | |
| 2021 | 17,480 | $763K | |
| 2022 | 14,473 | $669K | |
| 2023 | 17,612 | $1.04M | |
| 2024incomplete | 13,332 | $853K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 11% | 1,548 | 1,037 | $560K |
| G0378 | Hospital observation service, per hour | 10% | 1,954 | 1,213 | $512K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 9.8% | 1,859 | 1,450 | $484K |
| 80053 | Comprehensive metabolic panel | 8.9% | 13,285 | 7,301 | $440K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 8.8% | 1,257 | 1,015 | $436K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 7.8% | 2,461 | 1,935 | $385K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.3% | 364 | 288 | $260K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.9% | 10,837 | 6,755 | $195K |
| 80061 | Lipid panel | 2.8% | 3,072 | 2,310 | $136K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.7% | 2,354 | 1,684 | $131K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.6% | 2,024 | 1,617 | $129K |
| 71046 | Radiologic examination, chest; 2 views | 2.6% | 2,300 | 1,727 | $128K |
76 more codes
| 84443 | Thyroid stimulating hormone (TSH) | 2.3% | 3,408 | $115K |
| 36415 | Collection of venous blood by venipuncture | 1.5% | 13,870 | $75K |
| 74022 | 1.4% | 747 | $71K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.1% | 788 | $52K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.0% | 635 | $50K |
| 84439 | <1% | 2,146 | $49K | |
| 84484 | <1% | 871 | $42K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,735 | $36K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,405 | $35K |
| 85730 | <1% | 1,424 | $31K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,107 | $27K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 2,470 | $27K |
| 96376 | <1% | 343 | $27K | |
| 82607 | <1% | 990 | $25K | |
| S1015 | Iv tubing extension set | <1% | 170 | $24K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 448 | $22K |
| J2704 | Injection, propofol, 10 mg | <1% | 1,332 | $21K |
| 83690 | <1% | 1,459 | $21K | |
| 87081 | <1% | 1,298 | $20K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 899 | $20K |
| 82150 | <1% | 1,390 | $19K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 324 | $19K |
| 81003 | <1% | 1,880 | $18K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 149 | $17K |
| 82553 | <1% | 412 | $17K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 628 | $15K |
| 85610 | <1% | 1,576 | $15K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 449 | $14K |
| 82746 | <1% | 643 | $13K | |
| 81001 | <1% | 995 | $13K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,330 | $12K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 2,211 | $12K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 145 | $11K |
| 43248 | <1% | 22 | $11K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 146 | $10K |
| 80306 | <1% | 149 | $10K | |
| 94664 | <1% | 228 | $9K | |
| 81025 | <1% | 530 | $9K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 288 | $9K |
| 94760 | <1% | 660 | $9K | |
| 83880 | <1% | 119 | $8K | |
| 85379 | <1% | 126 | $7K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 59 | $6K |
| 82550 | <1% | 443 | $6K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,169 | $6K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 163 | $5K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 133 | $5K |
| A9270 | Non-covered item or service | <1% | 2,336 | $5K |
| 96367 | <1% | 133 | $4K | |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 74 | $4K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 16 | $4K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,474 | $4K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 152 | $4K |
| 43249 | <1% | 21 | $3K | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 572 | $2K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 86 | $2K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 59 | $2K |
| 83605 | <1% | 48 | $2K | |
| J3490 | Unclassified drugs | <1% | 639 | $2K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,041 | $1K |
| 85027 | <1% | 68 | $1K | |
| 71045 | Radiologic examination, chest; single view | <1% | 30 | $977.20 |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | <1% | 710 | $785.26 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 467 | $695.50 |
| 99051 | <1% | 132 | $673.69 | |
| 83735 | <1% | 27 | $529.46 | |
| 82728 | <1% | 29 | $499.99 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 340 | $493.26 |
| 83550 | <1% | 26 | $426.75 | |
| S0164 | Injection, pantoprazole sodium, 40 mg | <1% | 52 | $391.90 |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 14 | $374.51 |
| 87186 | <1% | 30 | $300.65 | |
| 83540 | <1% | 26 | $189.63 | |
| 81015 | <1% | 32 | $159.02 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 146 | $114.39 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 19 | $14.16 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialEDWARDS, MARK (CHIEF EXECUTIVE OFFICER)
| Provider | Location | Paid |
|---|---|---|
| The Cornerstone of Recovery, INC. | Louisville, TN | $5.93M |
| Addiction & Mental Health Services, LLC | Chattanooga, TN | $2.07M |
| Bradford Evolve Treatment Services, LLC | Knoxville, TN | $758K |
| Naab Road Surgical Group PC | Indianapolis, IN | $248K |
| Livingston Hospital and Healthcare Services, INC. | Grand Rivers, KY | $153K |
| Livingston Hospital and Healthcare Services, INC. | Eddyville, KY | $117K |
| West Houston Lung Center PA | Houston, TX | $5K |
| Edwards Internal Medicine PLLC | Germantown, TN | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.